Our studies uncovered the mechanisms by which EGFR regulated NSCLC metastasis and identified PLOD2 as an important regulator for NSCLC metastasis, paving the way for NSCLC diagnosis and clinic treatment. The gene discussed is PLOD2; the disease is non-small cell lung carcinoma.